 Rachel McMahan
Concepts (247)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ethanol | 8 | 2023 | 538 | 1.090 |
Why?
| | Dysbiosis | 3 | 2023 | 146 | 0.960 |
Why?
| | Intestines | 3 | 2022 | 326 | 0.920 |
Why?
| | Public Opinion | 2 | 2023 | 59 | 0.880 |
Why?
| | Burns | 5 | 2023 | 237 | 0.810 |
Why?
| | Inflammation | 7 | 2023 | 2478 | 0.720 |
Why?
| | Gastrointestinal Microbiome | 2 | 2022 | 501 | 0.640 |
Why?
| | Receptors, Antigen, T-Cell | 6 | 2017 | 615 | 0.640 |
Why?
| | Hepacivirus | 5 | 2017 | 229 | 0.620 |
Why?
| | Non-alcoholic Fatty Liver Disease | 5 | 2020 | 245 | 0.590 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2023 | 452 | 0.580 |
Why?
| | Liver | 6 | 2022 | 1637 | 0.570 |
Why?
| | Alcoholism | 4 | 2023 | 713 | 0.510 |
Why?
| | Alcohol Drinking | 2 | 2023 | 651 | 0.500 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2016 | 192 | 0.500 |
Why?
| | T-Lymphocytes | 7 | 2017 | 1737 | 0.480 |
Why?
| | Fatty Liver | 2 | 2013 | 210 | 0.450 |
Why?
| | T-Lymphocytes, Cytotoxic | 2 | 2010 | 154 | 0.410 |
Why?
| | Alcoholic Intoxication | 2 | 2023 | 62 | 0.390 |
Why?
| | Cancer Vaccines | 3 | 2010 | 137 | 0.390 |
Why?
| | Hepatitis C, Chronic | 2 | 2011 | 151 | 0.390 |
Why?
| | Monocytes | 3 | 2013 | 502 | 0.380 |
Why?
| | Epitopes, T-Lymphocyte | 2 | 2016 | 170 | 0.380 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2013 | 194 | 0.370 |
Why?
| | Mice | 22 | 2023 | 14863 | 0.360 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2010 | 171 | 0.340 |
Why?
| | Major Histocompatibility Complex | 3 | 2017 | 217 | 0.300 |
Why?
| | Lymphocyte Activation | 4 | 2007 | 1037 | 0.300 |
Why?
| | Antigens, CD | 1 | 2010 | 442 | 0.300 |
Why?
| | Animals | 26 | 2023 | 31698 | 0.290 |
Why?
| | Permeability | 3 | 2022 | 149 | 0.290 |
Why?
| | Macrophages, Alveolar | 3 | 2022 | 347 | 0.280 |
Why?
| | Myelin Basic Protein | 2 | 2003 | 45 | 0.260 |
Why?
| | Membrane Proteins | 2 | 2013 | 1018 | 0.250 |
Why?
| | Mice, Inbred C57BL | 9 | 2023 | 4692 | 0.250 |
Why?
| | Kupffer Cells | 2 | 2019 | 45 | 0.240 |
Why?
| | Macrophages | 6 | 2019 | 1261 | 0.240 |
Why?
| | Graft Rejection | 1 | 2007 | 513 | 0.230 |
Why?
| | Binge Drinking | 1 | 2023 | 32 | 0.220 |
Why?
| | Pneumonia | 2 | 2023 | 567 | 0.220 |
Why?
| | Hawaii | 1 | 2023 | 38 | 0.210 |
Why?
| | alpha-Defensins | 1 | 2022 | 11 | 0.210 |
Why?
| | Cytotoxicity, Immunologic | 4 | 2013 | 195 | 0.200 |
Why?
| | Delirium | 1 | 2023 | 66 | 0.200 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2022 | 38 | 0.200 |
Why?
| | Galectins | 2 | 2013 | 22 | 0.190 |
Why?
| | Tight Junctions | 1 | 2021 | 68 | 0.190 |
Why?
| | Intestinal Mucosa | 3 | 2021 | 532 | 0.190 |
Why?
| | Pneumococcal Infections | 1 | 2022 | 91 | 0.190 |
Why?
| | Astrocytes | 1 | 2022 | 162 | 0.180 |
Why?
| | Age Factors | 3 | 2022 | 2894 | 0.180 |
Why?
| | Cytokines | 4 | 2023 | 1840 | 0.180 |
Why?
| | Hepatitis C | 2 | 2016 | 219 | 0.180 |
Why?
| | Diet, High-Fat | 3 | 2020 | 225 | 0.180 |
Why?
| | Boston | 1 | 2020 | 75 | 0.170 |
Why?
| | Lipoproteins, LDL | 1 | 2020 | 128 | 0.170 |
Why?
| | Lymphatic Vessels | 1 | 2020 | 54 | 0.170 |
Why?
| | Lung | 4 | 2022 | 3559 | 0.170 |
Why?
| | Glomerulonephritis | 2 | 2018 | 45 | 0.170 |
Why?
| | Cholesterol, Dietary | 1 | 2019 | 15 | 0.160 |
Why?
| | Liver Cirrhosis, Experimental | 1 | 2019 | 11 | 0.160 |
Why?
| | Perilipin-2 | 1 | 2019 | 36 | 0.160 |
Why?
| | Congresses as Topic | 1 | 2020 | 195 | 0.160 |
Why?
| | Humans | 23 | 2023 | 114662 | 0.160 |
Why?
| | Gastrointestinal Tract | 1 | 2020 | 169 | 0.150 |
Why?
| | Liver Diseases | 1 | 2021 | 255 | 0.150 |
Why?
| | Osteopontin | 1 | 2018 | 32 | 0.150 |
Why?
| | Hepatocytes | 1 | 2019 | 195 | 0.150 |
Why?
| | Kidney Glomerulus | 1 | 2018 | 100 | 0.140 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1139 | 0.140 |
Why?
| | Antigens, Neoplasm | 2 | 2010 | 222 | 0.140 |
Why?
| | Immunotherapy | 3 | 2017 | 474 | 0.140 |
Why?
| | Neoplasms | 2 | 2008 | 2097 | 0.140 |
Why?
| | Histocompatibility Antigens Class I | 2 | 2016 | 172 | 0.140 |
Why?
| | Sevelamer | 1 | 2016 | 9 | 0.140 |
Why?
| | Receptor, Adenosine A2A | 1 | 2016 | 20 | 0.130 |
Why?
| | Adenosine A2 Receptor Agonists | 1 | 2016 | 19 | 0.130 |
Why?
| | Mice, Inbred BALB C | 4 | 2010 | 1143 | 0.130 |
Why?
| | Microbiota | 1 | 2023 | 647 | 0.130 |
Why?
| | Genomic Instability | 1 | 2016 | 38 | 0.130 |
Why?
| | Hepatitis A Virus Cellular Receptor 2 | 2 | 2013 | 26 | 0.120 |
Why?
| | Disease Models, Animal | 6 | 2021 | 3532 | 0.110 |
Why?
| | Ligands | 3 | 2023 | 561 | 0.110 |
Why?
| | Fructokinases | 1 | 2013 | 29 | 0.110 |
Why?
| | Sucrose | 1 | 2013 | 92 | 0.110 |
Why?
| | Mannose-Binding Lectins | 1 | 2013 | 13 | 0.110 |
Why?
| | Mice, Obese | 1 | 2013 | 53 | 0.110 |
Why?
| | Lectins, C-Type | 1 | 2013 | 61 | 0.110 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 447 | 0.110 |
Why?
| | Antibodies, Blocking | 2 | 2010 | 32 | 0.100 |
Why?
| | Cyclic AMP | 1 | 2013 | 227 | 0.100 |
Why?
| | Macrophage Activation | 1 | 2013 | 164 | 0.100 |
Why?
| | Chemokines | 2 | 2023 | 216 | 0.100 |
Why?
| | Herpesviridae Infections | 1 | 2013 | 138 | 0.100 |
Why?
| | Pregnancy | 1 | 2023 | 5518 | 0.090 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2013 | 351 | 0.090 |
Why?
| | Receptors, Cell Surface | 1 | 2013 | 355 | 0.090 |
Why?
| | Interleukin-10 | 1 | 2013 | 299 | 0.090 |
Why?
| | Immunity, Innate | 1 | 2016 | 720 | 0.090 |
Why?
| | Female | 9 | 2023 | 59493 | 0.090 |
Why?
| | Male | 11 | 2023 | 55583 | 0.090 |
Why?
| | Conserved Sequence | 1 | 2011 | 218 | 0.090 |
Why?
| | Genome, Viral | 1 | 2011 | 118 | 0.090 |
Why?
| | Peptide Library | 2 | 2010 | 81 | 0.090 |
Why?
| | Biomarkers | 1 | 2020 | 3408 | 0.090 |
Why?
| | Killer Cells, Natural | 1 | 2013 | 380 | 0.090 |
Why?
| | Vaccines, Subunit | 1 | 2010 | 41 | 0.080 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2010 | 80 | 0.080 |
Why?
| | Kidney | 2 | 2016 | 1188 | 0.080 |
Why?
| | Viral Proteins | 1 | 2011 | 281 | 0.080 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2010 | 194 | 0.080 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1016 | 0.080 |
Why?
| | Ischemia | 1 | 2011 | 362 | 0.080 |
Why?
| | T-Lymphocyte Subsets | 1 | 2010 | 383 | 0.080 |
Why?
| | Amino Acid Sequence | 3 | 2017 | 1982 | 0.080 |
Why?
| | Mice, Knockout | 4 | 2018 | 2568 | 0.080 |
Why?
| | Baculoviridae | 1 | 2008 | 44 | 0.070 |
Why?
| | Cloning, Molecular | 3 | 2004 | 522 | 0.070 |
Why?
| | H-2 Antigens | 1 | 2008 | 110 | 0.070 |
Why?
| | Insecta | 1 | 2008 | 64 | 0.070 |
Why?
| | Up-Regulation | 1 | 2010 | 807 | 0.070 |
Why?
| | Cross Reactions | 2 | 2017 | 117 | 0.070 |
Why?
| | Obesity | 1 | 2019 | 2508 | 0.070 |
Why?
| | Genetic Variation | 1 | 2011 | 870 | 0.070 |
Why?
| | Rats, Inbred Lew | 2 | 2003 | 91 | 0.070 |
Why?
| | Immune Tolerance | 1 | 2008 | 323 | 0.060 |
Why?
| | Colonic Neoplasms | 1 | 2008 | 215 | 0.060 |
Why?
| | Drug Design | 1 | 2006 | 148 | 0.060 |
Why?
| | DNA Primers | 1 | 2006 | 510 | 0.060 |
Why?
| | Acute Kidney Injury | 1 | 2011 | 637 | 0.060 |
Why?
| | Aging | 2 | 2020 | 1618 | 0.060 |
Why?
| | Interleukin-6 | 2 | 2023 | 676 | 0.060 |
Why?
| | Receptors, Interleukin-2 | 1 | 2004 | 64 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2319 | 0.060 |
Why?
| | Aged | 3 | 2023 | 19069 | 0.060 |
Why?
| | Case-Control Studies | 1 | 2010 | 3003 | 0.060 |
Why?
| | Cell Proliferation | 1 | 2010 | 2186 | 0.050 |
Why?
| | Recombinant Proteins | 2 | 2004 | 1230 | 0.050 |
Why?
| | Colorectal Neoplasms | 1 | 2010 | 615 | 0.050 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2010 | 959 | 0.050 |
Why?
| | Solubility | 1 | 2003 | 223 | 0.050 |
Why?
| | Body Surface Area | 1 | 2022 | 27 | 0.050 |
Why?
| | Burn Units | 1 | 2022 | 26 | 0.050 |
Why?
| | Occludin | 1 | 2021 | 10 | 0.050 |
Why?
| | Liver Cirrhosis | 1 | 2023 | 227 | 0.050 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2003 | 352 | 0.050 |
Why?
| | Autoimmunity | 1 | 2007 | 813 | 0.050 |
Why?
| | Colon | 1 | 2023 | 233 | 0.050 |
Why?
| | Malondialdehyde | 1 | 2021 | 28 | 0.050 |
Why?
| | Molecular Sequence Data | 2 | 2003 | 2785 | 0.050 |
Why?
| | Cell Line | 3 | 2017 | 2636 | 0.050 |
Why?
| | Streptococcus pneumoniae | 1 | 2022 | 133 | 0.050 |
Why?
| | Aspartate Aminotransferases | 1 | 2021 | 86 | 0.050 |
Why?
| | Lipid Peroxidation | 1 | 2021 | 139 | 0.050 |
Why?
| | Intercellular Junctions | 1 | 2020 | 33 | 0.050 |
Why?
| | Protein Structure, Tertiary | 1 | 2003 | 796 | 0.050 |
Why?
| | Mice, Transgenic | 3 | 2011 | 1947 | 0.040 |
Why?
| | Proteostasis | 1 | 2020 | 20 | 0.040 |
Why?
| | Alanine Transaminase | 1 | 2021 | 141 | 0.040 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2001 | 51 | 0.040 |
Why?
| | Histocompatibility Antigens | 1 | 2001 | 98 | 0.040 |
Why?
| | Epitopes | 2 | 2017 | 435 | 0.040 |
Why?
| | Interferon-gamma | 3 | 2010 | 719 | 0.040 |
Why?
| | Organ Specificity | 1 | 2020 | 268 | 0.040 |
Why?
| | Antigen Presentation | 1 | 2001 | 188 | 0.040 |
Why?
| | Aged, 80 and over | 1 | 2010 | 6345 | 0.040 |
Why?
| | Glutathione | 1 | 2021 | 293 | 0.040 |
Why?
| | Escherichia coli | 1 | 2003 | 720 | 0.040 |
Why?
| | Multivariate Analysis | 1 | 2023 | 1430 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 188 | 0.040 |
Why?
| | Hepatitis | 1 | 2019 | 45 | 0.040 |
Why?
| | Tumor Suppressor Proteins | 1 | 2020 | 282 | 0.040 |
Why?
| | Hippocampus | 1 | 2022 | 693 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 520 | 0.040 |
Why?
| | Gene Expression | 1 | 2003 | 1421 | 0.040 |
Why?
| | Peptides | 2 | 2017 | 848 | 0.040 |
Why?
| | Urinary Tract | 1 | 2018 | 36 | 0.040 |
Why?
| | Rats | 2 | 2003 | 4958 | 0.040 |
Why?
| | Isoantigens | 1 | 2017 | 17 | 0.040 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2016 | 687 | 0.040 |
Why?
| | HLA-A2 Antigen | 1 | 2017 | 36 | 0.040 |
Why?
| | Molecular Mimicry | 1 | 2017 | 35 | 0.040 |
Why?
| | Bacteria | 1 | 2023 | 725 | 0.040 |
Why?
| | Middle Aged | 2 | 2022 | 26733 | 0.040 |
Why?
| | Jurkat Cells | 1 | 2017 | 128 | 0.040 |
Why?
| | Signal Transduction | 2 | 2022 | 4512 | 0.030 |
Why?
| | Homeostasis | 1 | 2020 | 573 | 0.030 |
Why?
| | Homeodomain Proteins | 1 | 2020 | 463 | 0.030 |
Why?
| | Viral Nonstructural Proteins | 1 | 2017 | 54 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2003 | 1262 | 0.030 |
Why?
| | Glomerular Basement Membrane | 1 | 2016 | 7 | 0.030 |
Why?
| | Neutrophils | 1 | 2022 | 1176 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2023 | 12546 | 0.030 |
Why?
| | Protein Domains | 1 | 2017 | 207 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2019 | 444 | 0.030 |
Why?
| | Crystallography, X-Ray | 1 | 2017 | 402 | 0.030 |
Why?
| | Cognition | 1 | 2023 | 989 | 0.030 |
Why?
| | Young Adult | 1 | 2010 | 10466 | 0.030 |
Why?
| | Antigens, Viral | 1 | 2016 | 176 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2019 | 539 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2017 | 591 | 0.030 |
Why?
| | Glucose | 1 | 2019 | 896 | 0.030 |
Why?
| | Transcriptome | 1 | 2019 | 725 | 0.030 |
Why?
| | Muromegalovirus | 1 | 2013 | 13 | 0.030 |
Why?
| | Fructose | 1 | 2013 | 100 | 0.030 |
Why?
| | Receptors, Virus | 1 | 2013 | 75 | 0.030 |
Why?
| | Adult | 2 | 2011 | 30544 | 0.030 |
Why?
| | Interleukin-15 | 1 | 2013 | 74 | 0.030 |
Why?
| | Interleukin-12 | 1 | 2013 | 110 | 0.030 |
Why?
| | Models, Molecular | 1 | 2017 | 1369 | 0.030 |
Why?
| | Disease Progression | 1 | 2019 | 2380 | 0.020 |
Why?
| | Entropy | 1 | 2011 | 35 | 0.020 |
Why?
| | Genes, Viral | 1 | 2011 | 89 | 0.020 |
Why?
| | Energy Intake | 1 | 2013 | 427 | 0.020 |
Why?
| | Vaccination | 2 | 2010 | 1204 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2019 | 1072 | 0.020 |
Why?
| | Nucleotides | 1 | 2011 | 112 | 0.020 |
Why?
| | Weight Gain | 1 | 2013 | 453 | 0.020 |
Why?
| | Interleukin-7 Receptor alpha Subunit | 1 | 2010 | 11 | 0.020 |
Why?
| | Spodoptera | 1 | 2010 | 36 | 0.020 |
Why?
| | Immunodominant Epitopes | 1 | 2010 | 25 | 0.020 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2010 | 66 | 0.020 |
Why?
| | CD4 Antigens | 1 | 2010 | 123 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2010 | 170 | 0.020 |
Why?
| | Histocompatibility Antigen H-2D | 1 | 2008 | 21 | 0.020 |
Why?
| | Cross-Priming | 1 | 2008 | 18 | 0.020 |
Why?
| | CD11c Antigen | 1 | 2008 | 38 | 0.020 |
Why?
| | RNA, Viral | 1 | 2011 | 565 | 0.020 |
Why?
| | Amino Acids | 1 | 2011 | 448 | 0.020 |
Why?
| | Leukocytes, Mononuclear | 1 | 2010 | 493 | 0.020 |
Why?
| | Base Sequence | 1 | 2011 | 2114 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2013 | 3885 | 0.020 |
Why?
| | Chronic Disease | 1 | 2011 | 1578 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2008 | 435 | 0.010 |
Why?
| | Silver Staining | 1 | 2004 | 17 | 0.010 |
Why?
| | Genes, MHC Class II | 1 | 2004 | 69 | 0.010 |
Why?
| | Coculture Techniques | 1 | 2004 | 201 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2010 | 2710 | 0.010 |
Why?
| | Cell Lineage | 1 | 2004 | 309 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 923 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 797 | 0.010 |
Why?
| | Time Factors | 1 | 2011 | 6114 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2004 | 1083 | 0.010 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2001 | 154 | 0.010 |
Why?
| | Transfection | 1 | 2001 | 866 | 0.010 |
Why?
| | Fibroblasts | 1 | 2001 | 838 | 0.010 |
Why?
| | Adolescent | 1 | 2011 | 17841 | 0.010 |
Why?
|
|
McMahan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|